Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
98.58
(
-1.27%
)
Bitcoin
71,188.36
(
0.59%
)
News Focus
News Focus
Post# of 130524
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

brharris

Send PM Follow Ignore
Followers 49
Posts 3257
Boards Moderated 0
Alias Born 10/28/2012

brharris

Re: Tim696969 post# 111915

Thursday, 03/05/2015 1:22:54 PM

Thursday, March 05, 2015 1:22:54 PM

Post# of 130524
Already done as noted in the 8k issued yesterday:

On February 23, 2015, the Company filed an IND with the U.S. Food and Drug Administration for its Phase 2b clinical trial for Eltoprazine to treat Levodopa-Induced Dyskinesia in patients with Parkinson’s Disease.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote